(VIANEWS) – The NASDAQ ended the session with TherapeuticsMD (TXMD) rising 5.72% to $0.78 on Tuesday while NASDAQ Composite rose 0.71% to $15,129.09.


Today’s last reported volume for TherapeuticsMD is 4263630, 15.34% below its average volume of 5036250.

TherapeuticsMD’s last close was $0.74, 73.09% under its 52-week high of $2.75.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the ongoing quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $0.78 at 17:37 EST, way below its 52-week high of $2.75 and way above its 52-week low of $0.67.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s worth is higher than its 50-day moving average of $0.75 and way below its 200-day moving average of $1.04.

More news about TherapeuticsMD (TXMD).


Please enter your comment!
Please enter your name here